Engineered silica nanoparticles act as adjuvants to enhance allergic airway disease in mice. - Wikidata - wikimedia - TriplyDB

Engineered silica nanoparticles act as adjuvants to enhance allergic airway disease in mice.

Engineered silica nanoparticles act as adjuvants to enhance allergic airway disease in mice.

http://www.wikidata.org/entity/Q37059794

about

Assessing particle and fiber toxicology in the respiratory system: the stereology toolbox Overview about the localization of nanoparticles in tissue and cellular context by different imaging techniques Engineered nanomaterial exposure and the risk of allergic disease Significance of persistent inflammation in respiratory disorders induced by nanoparticles Silica Triggers Inflammation and Ectopic Lymphoid Neogenesis in the Lungs in Parallel with Accelerated Onset of Systemic Autoimmunity and Glomerulonephritis in the Lupus-Prone NZBWF1 Mouse Metal-Based Nanoparticles and the Immune System: Activation, Inflammation, and Potential Applications Surface modifications of silica nanoparticles are crucial for their inert versus proinflammatory and immunomodulatory properties.Induced T cell cytokine production is enhanced by engineered nanoparticles.AHAPS-functionalized silica nanoparticles do not modulate allergic contact dermatitis in mice Alterations of the Murine Gut Microbiome with Age and Allergic Airway Disease Preventing carbon nanoparticle-induced lung inflammation reduces antigen-specific sensitization and subsequent allergic reactions in a mouse model.Acute exposure to silica nanoparticles aggravate airway inflammation: different effects according to surface characteristics.Potential of nanoparticles for allergen-specific immunotherapy - use of silica nanoparticles as vaccination platform.Silica-Triggered Autoimmunity in Lupus-Prone Mice Blocked by Docosahexaenoic Acid Consumption.Preparation, characterization, and safety evaluation of poly(lactide-co-glycolide) nanoparticles for protein delivery into macrophages.Toxic and adjuvant effects of silica nanoparticles on ovalbumin-induced allergic airway inflammation in mice The Current State of Nanoparticle-Induced Macrophage Polarization and Reprogramming Research.Differential cytotoxic and inflammatory potency of amorphous silicon dioxide nanoparticles of similar size in multiple cell lines.Activation of human AML14.3D10 eosinophils by nanoparticles: Modulatory activity on apoptosis and cytokine production.Nanoparticle-allergen interactions mediate human allergic responses: protein corona characterization and cellular responses.Nanomaterials in the Context of Type 2 Immune Responses-Fears and Potentials.Emissions from commercial-grade charbroiling meat operations induce oxidative stress and inflammatory responses in human bronchial epithelial cells Mechanistic insight into the impact of nanomaterials on asthma and allergic airway disease.Combined Action of Human Commensal Bacteria and Amorphous Silica Nanoparticles on the Viability and Immune Responses of Dendritic Cells.Strain Differences in a Murine Model of Air Pollutant-induced Nonatopic Asthma and Rhinitis.Ozone-Induced Nasal Type 2 Immunity in Mice Is Dependent on Innate Lymphoid Cells.Specific Surface Modifications of Silica Nanoparticles Diminish Inflammasome Activation and In Vivo Expression of Selected Inflammatory Genes.The Toxicology of Engineered Nanomaterials in Asthma.Innate Lymphoid Cells Mediate Pulmonary Eosinophilic Inflammation, Airway Mucous Cell Metaplasia, and Type 2 Immunity in Mice Exposed to Ozone.Comparative modeling of exposure to airborne nanoparticles released by consumer spray products.Ozone-Induced Type 2 Immunity in Nasal Airways. Development and Lymphoid Cell Dependence in Mice.Zinc oxide nanoparticles provide an adjuvant effect to ovalbumin via a Th2 response in Balb/c mice.Dietary Docosahexaenoic Acid Prevents Silica-Induced Development of Pulmonary Ectopic Germinal Centers and Glomerulonephritis in the Lupus-Prone NZBWF1 Mouse

P2860

Q26777631-F442A987-43BF-4A36-99B0-E71E7B2B2590 Q26853219-47420F69-F6A0-407F-B4DA-96870A00CB41 Q28389510-44C94EA6-19B3-4A50-A6CA-F601C023BCF0 Q28390890-96478D5B-E9F6-4396-8587-F487FE3968FE Q28394117-22457647-55B6-4E49-ABE3-8CC96C32BEA6 Q28396375-4E5504EC-1A07-49A3-8E87-E32D7F882E77 Q33734404-87C39EF1-65AE-4970-A86E-76D04B70043D Q34036445-CC87F376-CE05-4B81-904D-192ACECE5519 Q34254990-E2C1EC0D-70A6-4432-BEF6-BE5E2530B84E Q35668255-16EE9500-7CC0-4EE2-B4B0-FA83881B44C0 Q35816920-C799AADF-F8D4-4EA8-83C4-52D83B0BD4F0 Q35917422-746DAEC2-FE0F-4107-B73B-8E52FA3E5D7C Q36056484-B5F5EE76-DCAD-47EF-B686-395BB2D7E8FA Q36101523-2CCA4B8A-45DF-4BFB-BC03-8F2535562A1A Q36111190-0D0DAC03-B557-4917-98C3-EFDFBB1D5194 Q36911253-EE96C9ED-AD36-4C89-8B25-7AA94E1CCC9E Q37690819-21B2513C-1992-4978-BD1F-21B851EA1E56 Q38718577-7CCA5567-5D62-4742-81A8-4BF61F23B3D3 Q38758598-0164E949-4B1B-4DFE-8BD4-8B71A3A7108C Q38803240-AEA9DF6B-3656-4F78-913D-B341206D8AB2 Q39294509-CFC59F3B-CAE6-469B-9AB1-BF2662356D16 Q41681093-551DB9C7-F240-4B24-BFCB-72F374C7FAF7 Q45817911-0A94F0B4-7462-4113-A3FD-0DB333620DCB Q46317140-3AF5245F-4606-4040-AF74-BC811200CD7B Q46435043-5E362865-105B-4CDF-ABCD-72363652C681 Q46525184-4512480A-9F39-4E34-8BE6-7DD8A6144328 Q47104687-E4F3378C-206B-4E66-A1E0-3E8823520760 Q50021034-C66AA6B6-8A35-46B8-9B77-3E6DDF414C7E Q50165380-385776E0-1F6C-4625-953C-716047848E31 Q52861979-DEFE5E9F-7D31-43C5-9A78-140053524428 Q53411910-A8FBD980-3286-403A-9263-9F932EB016EA Q54609284-97187BF9-3260-4D1E-9CDF-D1B6267C3649 Q58746511-9112225F-3896-41DC-B16B-D27DC63BEAEE

P2860

Engineered silica nanoparticles act as adjuvants to enhance allergic airway disease in mice.

http://www.wikidata.org/entity/Q37059794

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Engineered silica nanoparticle ...... lergic airway disease in mice.

@en

Engineered silica nanoparticle ...... lergic airway disease in mice.

@nl

type

label

Engineered silica nanoparticle ...... lergic airway disease in mice.

@en

Engineered silica nanoparticle ...... lergic airway disease in mice.

@nl

prefLabel

Engineered silica nanoparticle ...... lergic airway disease in mice.

@en

Engineered silica nanoparticle ...... lergic airway disease in mice.

@nl

P1433

Q37059794-D8AF5734-6F8F-4704-982F-116298C9AA10

P1476

Q37059794-CAA21CBF-A665-4FE1-BB09-FF1F1EE2213F

P2093

Q37059794-0318A4D4-E724-4BCF-8DF2-CBB8D7C4BE23

Q37059794-385E4C46-1315-4137-8FE2-1699C73F2AE5

Q37059794-46802C05-D5F8-4691-8800-42BDFEC6082A

Q37059794-4865AF4F-D2C4-41F2-8689-CE8D42C27BC7

Q37059794-6B4D2697-0096-4BFA-896C-F7AA54B6514B

Q37059794-761E177D-2526-4087-9778-46493E336B7C

Q37059794-8A615575-0A20-4B02-B675-15858D0FDC4E

Q37059794-A180A0A6-56E0-4F56-9BBE-BEF9CC736C8B

Q37059794-D05D79FB-3D14-4095-9112-B9F387A787FF

Q37059794-DAA4587B-EC46-44DE-AFBE-71591CA8FF1F

P2860

Q37059794-026D743C-0CE8-4929-AAFC-A471C7D48E24

Q37059794-055085C4-E718-43F1-AA21-539F1D1B4FF8

Q37059794-0950294B-E067-4A34-87D9-3A53D388DB93

Q37059794-0F0E0E1D-367F-46CB-B823-30FE8010A0C6

Q37059794-11AC46ED-6FEF-4ECD-82FF-6E7B9AD07214

Q37059794-13A9FF46-7D50-48E4-9CB3-255CACD9CEC3

Q37059794-16A0C00D-C129-43BF-BF28-8C02B56DA117

Q37059794-1F5E0920-D9B1-4D8F-A2E3-F4236975CBDD

Q37059794-2571ACE5-53D6-479F-8A10-44653EAF2CC3

Q37059794-2C643D5B-4003-417C-B79C-6FEB4D8594BE

P2888

Q37059794-FD062D09-7F73-4368-B0F6-3A20FCBB3D46

P304

Q37059794-5BCF4C88-BD33-465C-B40E-3B85ECF32B17

P31

Q37059794-D0CAA857-C8CD-448A-AE8F-659D35BCB1FD

P356

Q37059794-4DDD7605-9E40-4E01-955E-D42901475755

P478

Q37059794-24A4390C-C3CF-451A-88A4-012A07AE722B

P577

Q37059794-C078E431-F2C9-4A0E-A341-10B49B3A4AF3

P5875

Q37059794-9FA6F347-65F9-421F-92D1-B5576ED94772

P6179

Q37059794-70BA0886-4E51-4617-96C3-0EB4350CD5D8

P698

Q37059794-C94FCF90-F651-43C4-AF71-D82FC5D46A2F

P921

Q37059794-CD619E7B-7096-4739-9563-FA8527742B04

P932

Q37059794-3735A7D4-29E4-4847-AFD2-FCB5239AE562

P356

1743-8977-10-26

P1433

Particle and Fibre Toxicology

P1476

Engineered silica nanoparticle ...... lergic airway disease in mice.

@en

P2093

Barbara L Kaplan

http://www.w3.org/2001/XMLSchema#string

Christina Brandenberger

http://www.w3.org/2001/XMLSchema#string

Daven N Jackson-Humbles

http://www.w3.org/2001/XMLSchema#string

Gregory L Baker

http://www.w3.org/2001/XMLSchema#string

Jack R Harkema

http://www.w3.org/2001/XMLSchema#string

James G Wagner

http://www.w3.org/2001/XMLSchema#string

Lori A Bramble

http://www.w3.org/2001/XMLSchema#string

Nicole L Rowley

http://www.w3.org/2001/XMLSchema#string

Norbert E Kaminski

http://www.w3.org/2001/XMLSchema#string

Quanxuan Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Diseases caused by silica: mechanisms of injury and disease development

Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1α and IL-1β

Exposure assessment for atmospheric ultrafine particles (UFPs) and implications in epidemiologic research.

A role for mitochondria in NLRP3 inflammasome activation

Advances in PEGylation of important biotech molecules: delivery aspects

The nanosilica hazard: another variable entity.

Adverse effect of nano-silicon dioxide on lung function of rats with or without ovalbumin immunization

Nanoparticle exposure at nanotechnology workplaces: a review

The adjuvant effect of ambient particulate matter is closely reflected by the particulate oxidant potential

Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants

P2888

1743-8977-10-26

P304

26

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1743-8977-10-26

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

244479975

http://www.w3.org/2001/XMLSchema#string

P6179

1047727817

http://www.w3.org/2001/XMLSchema#string

P698

23815813

http://www.w3.org/2001/XMLSchema#string

P921

P932

3729411

http://www.w3.org/2001/XMLSchema#string